We have an exciting opportunity for an experienced Manager in Bioconjugation to join our Cambridge-based Bioconjugation Chemistry team. This is a lab-based, client-facing leadership role, combining hands-on scientific delivery with line management and project leadership responsibilities.

Abzena provides the most complete set of solutions in integrated early discovery to midphase biotherapeutic and ADC drug development services in the pharmaceutical industry. Working with a varied range of customers, from academic groups and small biotech to global pharma, on a diverse range of drug modalities including antibodies, fusion proteins and bioconjugates, Abzena supports the development and manufacture of better treatments for patients.

The Bioconjugation group in Cambridge delivers conjugation solutions supporting ADC, AOC and other bioconjugate development programmes. Using established chemistries and next-generation conjugation platforms, the team designs, synthesises and produces bioconjugates to support downstream bioassay and analytical evaluation. Work is conducted in close collaboration with Protein Engineering, Bioassay, Analytics and other cross-functional teams.

The successful candidate will provide technical leadership across multiple bioconjugation programmes, guiding complex conjugation strategies from design through delivery, while mentoring and developing scientists within the group. The role sits at the interface of science, project execution and client engagement, in a fast-paced and highly collaborative environment.

In return, we offer a competitive salary and benefits package, along with a collaborative, varied and challenging environment where you will be encouraged to develop your leadership skills, expand your scientific expertise and contribute to the continued growth of our bioconjugation capabilities.

UK EEO: Abzena is committed to promoting equal opportunities in employment. All our employees and any job applicants will receive equal treatment regardless of age, disability, gender reassignment, marital or civil partner status, pregnancy or maternity, race, colour, nationality, ethnic or national origin, religion or belief, sex or sexual orientation (“Protected Characteristics”).